Skip to main content
Contact Us
Subscribe
E-Edition
32°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Archives
Best of 2025
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
COMPASS Pathways Plc - American Depository Shares
(NQ:
CMPS
)
4.210
-0.330 (-7.27%)
Streaming Delayed Price
Updated: 4:00 PM EST, Feb 21, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about COMPASS Pathways Plc - American Depository Shares
< Previous
1
2
...
10
11
12
13
14
15
16
17
18
...
28
29
Next >
Psychedelic Stock Gainers And Losers From December 7, 2022
December 07, 2022
Via
Benzinga
Seelos Therapeutics, Numinus Wellness Among Top Psychedelic Movers Of Today
December 06, 2022
Via
Benzinga
Seelos Therapeutics, GH Research Among Top Psychedelic Movers Of Today
December 05, 2022
Via
Benzinga
Major Psychedelic Drug Stocks Went Up 7% This Week; Still Down 46% YTD
December 03, 2022
The 6 major psychedelic stocks researching the treatment of a variety of mental illnesses were UP 7% this week and are UP 3 % in the last 6 weeks. The 6 therapy clinic stocks went UP 3% this week and...
Via
Talk Markets
Psychedelic Stock Gainers And Losers From December 2, 2022
December 02, 2022
Via
Benzinga
Psychedelics And Treatment-Resistant Depression: An Overview Of COMPASS' Latest Trial Outcomes
November 16, 2022
(Part one of a four-part series)
Via
Benzinga
Psychedelic Stock Gainers And Losers From December 1, 2022
December 01, 2022
Via
Benzinga
Psychedelic Stock Gainers And Losers From November 30, 2022
November 30, 2022
Via
Benzinga
Revive Therapeutics, Seelos Therapeutics Among Top Psychedelic Movers Of Today
November 29, 2022
Via
Benzinga
Psyched: Full-Dose & Microdosing LSD Studies, Research Scope For Fed Funding, Consumption Sites And More
November 29, 2022
LSD Research Ramps Up: Full-Dose & Microdosing For Alzheimer's Studies Led By Beckley Foundation Coming Soon
Via
Benzinga
3 Big Trends Shaking Up Psychedelic Stocks
November 29, 2022
Major positive shifts are happening, but the field faces new headwinds too.
Via
The Motley Fool
Revive Therapeutics, Compass Pathways Among Top Psychedelic Movers Of Today
November 28, 2022
Via
Benzinga
Cannabis Category Performances Last Week Ranged From +5.2% To -2.3%
November 27, 2022
The 5 categories in the cannabis sector perform quite differently week to week and last week was no exception. This article is a summary of how each category performed last week, in descending order...
Via
Talk Markets
Psychedelic Stock Gainers And Losers From November 25, 2022
November 25, 2022
Via
Benzinga
Psychedelic Stock Gainers And Losers From November 24, 2022
November 24, 2022
Via
Benzinga
Psychedelic Stock Gainers And Losers From November 23, 2022
November 23, 2022
Via
Benzinga
Psychedelics And Treatment-Resistant Depression: Companies Weigh In On The Important Issue
November 23, 2022
(Part three of a four-part series) Have a look at previous stories:
Via
Benzinga
Psychedelic Stock Gainers And Losers From November 22, 2022
November 22, 2022
Via
Benzinga
Psyched: Musk's Empathy Tweets, Psychedelics In Congress, Oregon's Opt-Outs, MAPS' MDMA Trial And More
November 21, 2022
Elon Musk Joins Twitter Conversation Around Psychedelics: A Debate On Empathy
Via
Benzinga
Psychedelic Stock Gainers And Losers From November 21, 2022
November 21, 2022
Via
Benzinga
Psychedelic Drug Stocks Index Continued To Decline Last Week
November 20, 2022
This article highlights the performances of the 6 constituents in the munKNEE Psychedelic Drug Stocks Index last week and in the last 3 weeks and the extent to which each company is likely to encounter...
Via
Talk Markets
Biomind Labs, ATAI Life Sciences Among Top Psychedelic Movers Of Today
November 18, 2022
Via
Benzinga
Psychedelics And Treatment-Resistant Depression: Reactions To COMPASS' Published Results
November 18, 2022
(Part two of a four-part series) See previous story in this series: Psychedelics And Treatment-Resistant Depression: An Overview Of COMPASS’ Latest Trial Outcomes
Via
Benzinga
Revive Therapeutics, GH Research Among Top Psychedelic Movers Of Today
November 17, 2022
Via
Benzinga
Psychedelic Stock Gainers And Losers From November 16, 2022
November 16, 2022
Via
Benzinga
GH Research, Seelos Therapeutics Among Top Psychedelic Movers Of Today
November 15, 2022
Via
Benzinga
Clinical Stage Psychedelic Stock Index Up 6%; Therapy Clinic Stocks Down 8%
November 14, 2022
We highlight the performance of our Psychedelic Drug Stocks Index and the 6 psychedelic stocks that research the treatment of a variety of mental illnesses based on the use of different psychedelic...
Via
Talk Markets
A Comparison Of 5 Psychedelic ETFs And Indices
November 11, 2022
A look at 2 psychedelic ETFs and 3 tracking (non-trading) indices in the sector.
Via
Talk Markets
Compass Pathways, Mind Medicine Among Top Psychedelic Movers Of Today
November 10, 2022
GAINERS: Compass Pathways (NASDAQ:CMPS) shares closed up 12.17% at $10.05
Via
Benzinga
Seelos Therapeutics, GH Research Among Top Psychedelic Movers Of Today
November 09, 2022
GAINERS: GH Research (NASDAQ:GHRS) shares closed up 7.91% at $9.96 LOSERS:
Via
Benzinga
< Previous
1
2
...
10
11
12
13
14
15
16
17
18
...
28
29
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.